These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30060575)

  • 1. Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer.
    Chaddad A; Kucharczyk MJ; Niazi T
    Cancers (Basel); 2018 Jul; 10(8):. PubMed ID: 30060575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis.
    Chaddad A; Niazi T; Probst S; Bladou F; Anidjar M; Bahoric B
    Front Oncol; 2018; 8():630. PubMed ID: 30619764
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    Shiradkar R; Ghose S; Jambor I; Taimen P; Ettala O; Purysko AS; Madabhushi A
    J Magn Reson Imaging; 2018 Dec; 48(6):1626-1636. PubMed ID: 29734484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
    Gong L; Xu M; Fang M; Zou J; Yang S; Yu X; Xu D; Zhou L; Li H; He B; Wang Y; Fang X; Dong D; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1102-1109. PubMed ID: 32212356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.
    Abdollahi H; Mofid B; Shiri I; Razzaghdoust A; Saadipoor A; Mahdavi A; Galandooz HM; Mahdavi SR
    Radiol Med; 2019 Jun; 124(6):555-567. PubMed ID: 30607868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Clinically Significant Cancer Using Radiomics Features of Pre-Biopsy of Multiparametric MRI in Men Suspected of Prostate Cancer.
    Ogbonnaya CN; Zhang X; Alsaedi BSO; Pratt N; Zhang Y; Johnston L; Nabi G
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-based radiomics signature for localized prostate cancer: a new clinical tool for cancer aggressiveness prediction? Sub-study of prospective phase II trial on ultra-hypofractionated radiotherapy (AIRC IG-13218).
    Gugliandolo SG; Pepa M; Isaksson LJ; Marvaso G; Raimondi S; Botta F; Gandini S; Ciardo D; Volpe S; Riva G; Rojas DP; Zerini D; Pricolo P; Alessi S; Petralia G; Summers PE; Mistretta FA; Luzzago S; Cattani F; De Cobelli O; Cassano E; Cremonesi M; Bellomi M; Orecchia R; Jereczek-Fossa BA
    Eur Radiol; 2021 Feb; 31(2):716-728. PubMed ID: 32852590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness.
    Damascelli A; Gallivanone F; Cristel G; Cava C; Interlenghi M; Esposito A; Brembilla G; Briganti A; Montorsi F; Castiglioni I; De Cobelli F
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33810222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time.
    Chaddad A; Daniel P; Desrosiers C; Toews M; Abdulkarim B
    IEEE J Biomed Health Inform; 2019 Mar; 23(2):795-804. PubMed ID: 29993848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.
    Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T
    Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Novel, Multi-Parametric, MRI-Based Radiomic Nomogram for Differentiating Between Clinically Significant and Insignificant Prostate Cancer.
    Zhang Y; Chen W; Yue X; Shen J; Gao C; Pang P; Cui F; Xu M
    Front Oncol; 2020; 10():888. PubMed ID: 32695660
    [No Abstract]   [Full Text] [Related]  

  • 14. Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences.
    Qin JB; Liu Z; Zhang H; Shen C; Wang XC; Tan Y; Wang S; Wu XF; Tian J
    Med Sci Monit; 2017 May; 23():2168-2178. PubMed ID: 28478462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of prostate gland radiomic features in identifying the Gleason score.
    Gong L; Xu M; Fang M; He B; Li H; Fang X; Dong D; Tian J
    Comput Biol Med; 2022 May; 144():105318. PubMed ID: 35245698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2-weighted MRI-derived textural features reflect prostate cancer aggressiveness: preliminary results.
    Nketiah G; Elschot M; Kim E; Teruel JR; Scheenen TW; Bathen TF; Selnæs KM
    Eur Radiol; 2017 Jul; 27(7):3050-3059. PubMed ID: 27975146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    Zhang Z; Xu H; Xue Y; Li J; Ye Q
    J Magn Reson Imaging; 2019 Feb; 49(2):556-564. PubMed ID: 30173421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically significant prostate cancer detection on MRI: A radiomic shape features study.
    Cuocolo R; Stanzione A; Ponsiglione A; Romeo V; Verde F; Creta M; La Rocca R; Longo N; Pace L; Imbriaco M
    Eur J Radiol; 2019 Jul; 116():144-149. PubMed ID: 31153556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores.
    Wibmer A; Hricak H; Gondo T; Matsumoto K; Veeraraghavan H; Fehr D; Zheng J; Goldman D; Moskowitz C; Fine SW; Reuter VE; Eastham J; Sala E; Vargas HA
    Eur Radiol; 2015 Oct; 25(10):2840-50. PubMed ID: 25991476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.